Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment ...

BTIG analyst Jake Fuller upgraded Instacart (CART) to Buy from Neutral with a $58 price target The immediate catalyst for the upgrade is a ...

In recent trading, P3 Health Partners Inc (PIII) stock price has shown some volatility, fluctuating -13.35% over the last five trades a ...

Energy and Infrastructure Analyst Lewis holds a conference call with Director of IR Friedlander on January 21 at 11 am hosted by BTIG.Stay ...

Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.

DA Davidson upgraded Clearwater Analytics (CWAN) to Buy from Neutral with a price target of $32, down from $35. The company's ...

FREYR Battery Inc (FREY) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.25 or -9.62% from the prior close of $2.6. The stock opened at $2.52 and touched a low of $2.32 ...

Each successive downgrade has cost Palo Alto stock a few more points of market capitalization. Today, the stock fell 4% to ...

BTIG analyst Gray Powell keeps a Buy rating and $30 price target on SentinelOne (S) but names the stock the firm’s Top Pick in Security & Infrastructure Software for 2025. The stock is ...

BTIG's Krinsky noted that while equity markets in the first half of 2024 were fueled mostly by the surge in mega-cap names ...

The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...

As of December 3, 2024, the average one-year price target for Avalo Therapeutics is $35.70/share. The forecasts range from a low of $35.35 to a high of $36.75. The average price target represents ...